ARTICLE | Clinical News
Monoclonal antibody to treat fibrin-containing tumors regulatory update
February 20, 2001 8:00 AM UTC
MABA received U.S. Patent No. 6,187,593 covering methods for using its MH-1 monoclonal antibody in conjunction with a cytotoxic reagent to treat malignant and benign tumors containing fibrin. ...